Clinical Trials Directory

Trials / Unknown

UnknownNCT02705430

Effect of EPA-DHA Supplement, Life Style Modification Standard Treatment on Clinical Outcome Lipid Membrane Composition in Type 2 Diabetes

Effect of EPA-DHA Supplementation, Life Style Modification or Standard Treatment on Clinical Outcome and Lipid Membrane Composition in Type 2 Diabetic Patients: a 3 Months Perspective Randomized Pilot Study.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Rabin Medical Center · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The aim of the present study is: to examine some of the mechanisms by which a change in life style alone or supplemented with a diet supplemented in n-3 PUFA, and associated with this computerized life style regulation reduces the development of diabetic complication in a small population based study. (The NewMe™ / Eco-fusion, Ltd is a science-driven lifestyle change program for better living -www.eco-fusion.com)

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTEPA and DHA capsules of 2 g/dayEPA and DHA capsules of 2 g/day
BEHAVIORALStress management phone application (Eco Fusion Mentally)Stress management phone application (Eco Fusion Mentally)
BEHAVIORALlife style program using a mobile phone (Eco Mentally and NewMe)life style program using a mobile phone (Eco Mentally and NewMe)
DEVICEmobile phonemobile phone

Timeline

Start date
2018-06-20
Primary completion
2019-03-01
Completion
2019-03-01
First posted
2016-03-10
Last updated
2019-01-09

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02705430. Inclusion in this directory is not an endorsement.